Label: GERI-TUSSIN DM- dextromethorphan hbr, guaifenesin liquid

  • NDC Code(s): 57896-661-08, 57896-661-16
  • Packager: Geri-Care Pharmaceuticals, Corp
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 23, 2020

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    per 5 mL teaspoonful

    Dextromethorphan HBr - 10 mg

    Guaifenesin - 100 mg

  • PURPOSE

    Purpose

    Cough Suppressant

    Expectorant

  • INDICATIONS & USAGE

    Uses

    • temporarilyrelievescoughduetominorthroatand bronchial irritation
    • helps loosen phlegm (mucus)
    • helps thin bronchial secretions to make coughs more productive
  • WARNINGS

    Warnings

    Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease) or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

    Do not use if you have ever had an allergic reaction to any of the ingredients in this product.

    Ask a doctor before use if you have

    • a cough with too much phlegm (mucus)
    • a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema

    Stop use and ask a doctor if

    cough lasts more than 7 days, comes back or is accompanied by fever, rash, or headache that lasts. These could be signs of a serious condition.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Directions

    • take every 4 hours as needed, or as directed by a doctor
    • do not take more than 6 doses in 24 hours
    • do not exceed recommended dose
     Adults and children 12 years and over 2 teaspoonfuls (10 mL)
     Children under 12 years do not use

  • INACTIVE INGREDIENT

    Inactive ingredients: artificial and natural cherry flavor, citric acid, FD&C Red #40, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate, sucralose, sucrose COMPARE TO THE ACTIVE INGREDIENTS OF

  • QUESTIONS

    Distributed by: GERI-CARE PHARMACEUTICALS CORP. 1650 63rd Street Brooklyn, NY 11204

  • PRINCIPAL DISPLAY PANEL

    gerritussDM

    gerritussinDM8oz

  • INGREDIENTS AND APPEARANCE
    GERI-TUSSIN  DM
    dextromethorphan hbr, guaifenesin liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-661
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE10 mg  in 5 mL
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN100 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    SUCROSE (UNII: C151H8M554)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:57896-661-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product05/01/2019
    2NDC:57896-661-08237 mL in 1 BOTTLE; Type 0: Not a Combination Product12/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34105/01/2019
    Labeler - Geri-Care Pharmaceuticals, Corp (611196254)